The global Oscillating Positive Expiratory Pressure (OPEP) Devices Market was valued at US$ 128.8 Million in 2021 and is expected to reach US$ 195.2 Million by 2029, expanding at a CAGR of 5.3% over the forecast period, finds Future Market Insights (FMI) in a recent market survey.
Data Points
Market Insights
Market Value 2021
USD 128.8 Million
Market Value 2022
USD 135.9 Million
Market Value 2029
USD 195.2 Million
CAGR 2022 to 2029
5.3%
Key Players
The key players are Smiths Medical, Inc., Allergan plc, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, WyMedical Pty Ltd, AirPhysio, Medica Holdings LLC., and D-R BURTON HEALTHCARE
Share of Top 5 Countries
76.4%
The major factors driving the oscillating positive expiratory pressure devices market include the growing pervasiveness of chronic pulmonary diseases and rising technological advancements.
In addition, the increased elderly population together with higher occurrences of chronic conditions boost the OPEP devices market development. The growing prevalence of COPD (chronic obstructive pulmonary disease) together with asthma is another primary driving factor for the market.
The oscillating positive expiratory pressure (OPEP) devices market holds nearly 8.9% market value share of the US$ 1,452.8 Million airway management device market in 2021.
The key participants in the global OPEP market are focused on enhancing their product availability via various collaborations and agreements across the world. Manufacturers in the OPEP device market often rely heavily on the distributors as majorly they are directly selling the product to healthcare facilities.
Driven by this, sales of oscillating positive expiratory pressure (OPEP) devices are expected to rise at a 5.3% CAGR through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
5.34%
H1, 2022 Projected
5.31%
H1, 2022 Outlook
5.21%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 14 ↓
Disease burden and device regulatory scenario are dynamics that impact the market for oscillating positive expiratory pressure (OPEP) devices. The market is subject to be influenced by macro, regulatory, and industrial factors.
Expansion of production facilities and exporting products across the globe as viable solutions for non-pharmacological therapy for greater mobilization are key market developments. The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 10 BPS.
According to FMI analysis, the oscillating positive expiratory pressure (OPEP) devices market is expected to decline by 14 Basis Share Point (BPS) in H1-2022 (O) from H1-2021. Variations in the price of products subject to innovative incorporations, and lower adoption of OPEP devices in low-income economies are factors that are leading toward a reduction in the BPS value for the oscillating positive expiratory pressure (OPEP) devices market.
Conversely, other market segments are expected to perform objectively and achieve lucrative growth prospects in the next half of the projection period, owing to the adoption of OPEP devices as an alternative to conventional chest physiotherapy.
2014 to 2021 Oscillating Positive Expiratory Pressure (OPEP) Devices Market Demand Outlook Compared to 2022 to 2029 Forecast
Sales of oscillating positive expiratory pressure (OPEP) devices grew at a CAGR of 5.0% between 2014 and 2021.
The primary factors boosting the development of the oscillating positive expiratory pressure (OPEP) devices market include the growing prevalence of lung diseases like asthma, chronic obstructive pulmonary disease (COPD), and others; the rising geriatric population, and the advantages offered by these devices.
The OPEP devices are the devices that are utilized for clearing mucous from the airways. These devices help in relaxing the walls of the lungs and make breathing easy.
The demand for mucous clearance devices like OPEP devices is increasing due to the growing prevalence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. As per the World Health Organization (WHO), COPD exacerbations are key events in the history of COPD, and related disability and mortality are expected to contribute to increasing the global demand for these OPEP devices over the forecast period.
In addition, the encouraging growth prospects are owing to the inventive approach adopted by key players in developing devices, and the growing adoption of OPEP devices among patients suffering from respiratory diseases.
Considering this, FMI expects the global oscillating positive expiratory pressure (OPEP) devices market to grow at a CAGR of 5.3% through 2029.
Find your sweet spots for generating winning opportunities in this market.
Which Factors Are Restraining Demand for Oscillating Positive Expiratory Pressure (OPEP) Devices?
Lower awareness about OPEP devices and limited product availability are the major factors hampering the growth of the market. Lower awareness about the OPEP devices among healthcare professionals as well as people suffering from pulmonary diseases is the prime restraint in the growth of the OPEP devices market. Lower awareness is often the result of small-scale manufacturers in various countries, doing lesser product marketing, with relatively lesser availability of the efficacy data and reluctance of healthcare professionals to prescribe the device to patients.
Most of the manufacturers in the OPEP devices market cater to a specific country or region which results in lower product availability in various countries. Although these devices are available on online platforms, the regional availability of these devices is low due to a limited number of suppliers. Thus, the limited product availability is expected to restrain market growth.
Country-wise Insights
What Makes the USA a Large Market for Oscillating Positive Expiratory Pressure (OPEP) Devices?
The USA is estimated to account for around 94.4% of the North America oscillating positive expiratory pressure (OPEP) devices market in 2022.
The USA market growth is due to the factors, such as the increasing prevalence of respiratory diseases like COPD and asthma, growing adoption of OPEP devices, and ease of availability of devices at various distribution outlets.
According to the report published by the CDC (Center for Disease Control and Prevention), approximately, 1 in 13 individuals in America are on average affected by asthma every year. This approximately creates a patient population of around 25 million in the US alone. Additionally, the availability of advanced medical infrastructure and early accessibility of new devices and products is supporting the development of the market in the USA
Why is the United Kingdom Considered a Lucrative Oscillating Positive Expiratory Pressure (OPEP) Devices Market?
The United Kingdom is estimated to account for 20.0%of Europe's oscillating positive expiratory pressure (OPEP) devices market in 2022.
The growth of the market in the United Kingdom is attributable to the increasing emphasis of the European government on developing an improved treatment for respiratory disorders, the increasing rate of people smoking tobacco, and growing healthcare expenditure. In 2019, 16% of young adults who smoked were aged between 18 and 24 years. People between 25 and 34 years of age in the United Kingdom show the highest amount of smokers with 19% of the population in the United Kingdom Smoking considerably surges health risk for several chronic diseases resulting in early death.
What are the Factors Fueling the Demand for Oscillating Positive Expiratory Pressure (OPEP) Devices in Japan?
The oscillating positive expiratory pressure (OPEP) devices market in Japan is estimated to be worth US$ 4.0 Million in 2022 in the global market.
In Japan, the oscillating positive expiratory pressure (OPEP) devices market is largely propelled by the growing prevalence of respiratory diseases and the rising number of deaths because of air pollution. Moreover, there is continuous growth in the elderly population in Japan. The geriatric population is susceptible to diseases such as asthma. Also, the cost of medications and hospitalization is higher for elderly people when compared with adults. In addition, the treatment is very difficult in the geriatric population due to the pathophysiology of asthma. This is resulting in better adoption of OPEP devices in the country.
How will the Oscillating Positive Expiratory Pressure (OPEP) Devices Market Expand across India?
Demand for oscillating positive expiratory pressure (OPEP) devices in India is expected to rise at around 5.8% CAGR over the forecast period.
India is expected to witness significant growth over the forecast period owing to a growing patient pool, increasing levels of air pollution, and considerable improvement in the healthcare industry. In India, air pollution is rising at a significant pace and is accountable for leading to adverse effects on human health, including several respiratory diseases. Moreover, the increasing cases of respiratory diseases, including bronchiectasis, chronic obstructive pulmonary disease (COPD), and asthma are driving the market in India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Demand for mouthpiece PEP devices to continue gaining Traction
By product type, mouthpiece PEP devices are anticipated to hold the maximum share of 96.8% in 2022, expanding at a rate of nearly 5.3% during the forecast period.
The advantages offered by the mouthpiece PEP devices include improved lung function and reduced pulmonary exacerbations. These devices offer back pressure to the airways during expiration. Positive expiratory pressure (PEP) devices are mostly better than other mucous clearance approaches in decreasing pulmonary exacerbations for cystic fibrosis patients.
Why chronic obstructive pulmonary disease (COPD) will hold the most of the market share?
By indication, chronic obstructive pulmonary disease (COPD) will lead the market and is projected to account for 33.7% of the total market revenue share in 2022.
COPD is caused due to obstruction in the airways leading to trouble in breathing, due to the key factor of tobacco smoking. According to the WHO (World Health Organization) report, in 2019, the chronic obstructive pulmonary disease is the third primary cause of death across the world.
Growing patient awareness for building a common platform for COPD patients is expected to boost the development of the segment over the forecast period. For instance, November is considered the National COPD month globally. Over the entire month, the COPD (chronic obstructive pulmonary disease) Foundation join forces with several respiratory healthcare organizations to hold several online and in-person activities for the COPD communal members to improve exposure.
Why Hospital Pharmacies projected maximum growth in the Oscillating Positive Expiratory Pressure (OPEP) Devices Market?
By distribution channel, the hospital pharmacies segment is anticipated to hold the maximum share of 53.1% in 2022, expanding at a rapid rate of 5.2% CAGR during the forecast period.
The number of hospitals is growing, particularly in the developed nations, which is anticipated to surge the demand for oscillating positive expiratory pressure (OPEP) devices in hospitals. Moreover, the presence of well-developed infrastructure and the availability of advanced equipment supports the development of the segment. Also, the increasing patient admission in hospitals is increasing the use of these devices in hospitals, thus driving sales in hospital pharmacies.
Competitive Landscape
Companies operating in the oscillating positive expiratory pressure (OPEP) devices market are competitive by nature, with the presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:
In May 2021, Monaghan Medical Corporation (Monaghan) and Captis announced their agreement to a three-year contract creating a partnership between two industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold-standard medical devices, with Captis’ desire to drive process efficiencies and value-driven healthcare spending.
Scope of the Report
Attribute
Details
Forecast Period
2014 to 2021
Historical Data Available for
2022 to 2029
Market Analysis
USD Million for Value
Key Countries Covered
USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa, Northern Africa, Turkey
Key Segments Covered
Product Type, Indication, Distribution Channel, and Region
Key Companies Profiled
Smiths Medical, Inc.
Allergan plc
Monaghan Medical Corporation & Trudell Medical International
Others
PARI GmbH
WyMedical Pty Ltd
R. Cegla GmbH & Co. KG
D-R BURTON HEALTHCARE
AirPhysio
Medica Holdings, LLC.
Report Coverage
Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Oscillating Positive Expiratory Pressure (OPEP) Devices Market by Category
By Product Type:
Face Mask PEP Devices
Mouthpiece PEP Devices
Bottle PEP Devices
By Indication:
COPD
Asthma
Atelectasis
Bronchitis
Bronchiectasis
Cystic Fibrosis
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
The global oscillating positive expiratory pressure (OPEP) devices market is worth US$ 128.8 Million in 2021 and is set to expand 1.4X over the forecasted years owing to the rising cases of respiratory diseases and rising technological advancements.
The sales of oscillating positive expiratory pressure (OPEP) devices in the market has grown at a CAGR of nearly 5.0% between 2014 and 2021. The need for oscillating positive expiratory pressure (OPEP) devices is growing because of the ease of use of OPEP devices, the demand for drug-free and non-invasive therapy, and the rising prevalence of chronic obstructive pulmonary disease (COPD).
The oscillating positive expiratory pressure (OPEP) devices market is expected to reach US$ 195.2 Million by the end of 2029 with sales revenue expected to register a CAGR of 5.3% over the forecast period
North America currently holds the largest market share in oscillating positive expiratory pressure (OPEP) devices. North America currently holds 53.5% of 2021 of the global market share in the oscillating positive expiratory pressure (OPEP) devices market with the USA being the leading contributor with a market value of over US$ 65.1 Million in 2021.
Demand for oscillating positive expiratory pressure (OPEP) devices market is expected to register growth in Europe at a rate of 5.2% CAGR during the forecast period.
The oscillating positive expiratory pressure (OPEP) devices in Japan are likely to observe growth with an impressive CAGR of 5.6% during the forecast period. The market in Japan is driven by the growing prevalence of respiratory diseases and the rising number of deaths because of air pollution.
An increasing number of studies to support the effectiveness ad efficacy of OPEP devices, technological advancement, and increasing product approvals are key trends driving sales of oscillating positive expiratory pressure (OPEP) devices market across the globe.
China’s oscillating positive expiratory pressure (OPEP) devices market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.0% CAGR during the forecast period. The South Korean market is expected to exhibit healthy growth of 5.3% CAGR during the forecast period.
The USA, Germany, the United Kingdom, France, and Italy are the top 5 countries that are driving the demand for oscillating positive expiratory pressure (OPEP) devices market.
Leading companies of oscillating positive expiratory pressure (OPEP) devices are Smiths Medical, Inc., Allergan plc, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, WyMedical Pty Ltd, AirPhysio, Medica Holdings LLC., and D-R BURTON HEALTHCARE.
Table of Content
1. Executive Summary | Oscillating Positive Expiratory Pressure (OPEP) Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation Trends
4. Key Success Factors
4.1. Product Adoption / Awareness Analysis
4.2. Product vs. Indication Matrix
4.3. Patient Sentiment Analysis
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis by Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer-Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Market Value Analysis 2014 to 2021 and Forecast, 2022 to 2029
6.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
6.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.2. Forecast Factors - Relevance & Impact
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) and Volume Analysis by Product Type, 2014 to 2021
8.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by Product Type, 2022 to 2029
8.3.1. Face Mask PEP Devices
8.3.2. Mouthpiece PEP Devices
8.3.3. Bottle PEP Devices
8.4. Market Attractiveness Analysis by Product Type
9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis by Indication, 2014 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Indication, 2022 to 2029
9.3.1. COPD
9.3.2. Asthma
9.3.3. Atelectasis
9.3.4. Bronchitis
9.3.5. Bronchiectasis
9.3.6. Cystic Fibrosis
9.3.7. Others
9.4. Market Attractiveness Analysis by Indication
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by Distribution Channel, 2014 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Distribution Channel, 2022 to 2029
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies/ Online Sales
10.4. Market Attractiveness Analysis by Distribution Channel
11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) and Volume Analysis by Region, 2014 to 2021
11.3. Current Market Size (US$ Million) and Volume Analysis and Forecast by Region, 2022 to 2029
11.3.1. North America
11.3.2. Europe
11.3.3. Latin America
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis by Region
12. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
12.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints - Impact Analysis
13. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
13.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
14.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Italy
14.3.1.4. United Kingdom
14.3.1.5. BENELUX
14.3.1.6. Russia
14.3.1.7. Rest of Europe
14.3.2. By Product Type
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
15.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
15.3.1. By Country
15.3.1.1. Thailand
15.3.1.2. India
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
16.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
17.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Indication
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
18.1. Introduction
18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2021
18.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. South Africa
18.3.1.3. North Africa
18.3.1.4. Turkey
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Indication
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Indication
18.4.4. By Distribution Channel
18.5. Drivers and Restraints - Impact Analysis
19. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Market Analysis
19.2.1. Introduction
19.2.2. Market Volume (Million Units) and Value (US$ Million) Analysis and Forecast by Market Taxonomy
19.2.2.1. By Product Type
19.2.2.2. By Indication
19.2.2.3. By Distribution Channel
19.2.3. China Market - Competition Landscape
19.3. India Market Analysis
19.3.1. Introduction
19.3.2. Market Volume (Million Units) and Value (US$ Million) Analysis and Forecast by Market Taxonomy
19.3.2.1. By Product Type
19.3.2.2. By Indication
19.3.2.3. By Distribution Channel
19.3.3. India Market - Competition Landscape
19.4. Brazil Market Analysis
19.4.1. Introduction
19.4.2. Market Volume (Million Units) and Value (US$ Million) Analysis and Forecast by Market Taxonomy
19.4.2.1. By Product Type
19.4.2.2. By Indication
19.4.2.3. By Distribution Channel
19.4.3. Brazil Market - Competition Landscape
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Smiths Medical, Inc.
21.3.1.1. Company Overview
21.3.1.2. Analyst Commentary
21.3.1.3. Financial Analysis
21.3.1.4. Product Portfolio
21.3.1.5. Profitability by Market Segments (Product and Region)
21.3.1.6. Sales Footprint
21.3.1.7. Strategy Overview
21.3.1.7.1. Marketing Strategy
21.3.1.7.2. Product Strategy
21.3.1.7.3. Channel Strategy
21.3.2. Allergan plc.
21.3.2.1. Company Overview
21.3.2.2. Analyst Commentary
21.3.2.3. Financial Analysis
21.3.2.4. Product Portfolio
21.3.2.5. Profitability by Market Segments (Product and Region)
21.3.2.6. Sales Footprint
21.3.2.7. Strategy Overview
21.3.2.7.1. Marketing Strategy
21.3.2.7.2. Product Strategy
21.3.2.7.3. Channel Strategy
21.3.3. Monaghan Medical Corporation & Trudell Medical International
21.3.3.1. Company Overview
21.3.3.2. Analyst Commentary
21.3.3.3. Financial Analysis
21.3.3.4. Product Portfolio
21.3.3.5. Profitability by Market Segments (Product and Region)
21.3.3.6. Sales Footprint
21.3.3.7. Strategy Overview
21.3.3.7.1. Marketing Strategy
21.3.3.7.2. Product Strategy
21.3.3.7.3. Channel Strategy
21.3.4. R. Cegla GmbH & Co. KG
21.3.4.1. Company Overview
21.3.4.2. Analyst Commentary
21.3.4.3. Financial Analysis
21.3.4.4. Product Portfolio
21.3.4.5. Profitability by Market Segments (Product and Region)
21.3.4.6. Sales Footprint
21.3.4.7. Strategy Overview
21.3.4.7.1. Marketing Strategy
21.3.4.7.2. Product Strategy
21.3.4.7.3. Channel Strategy
21.3.5. PARI GmbH
21.3.5.1. Company Overview
21.3.5.2. Analyst Commentary
21.3.5.3. Financial Analysis
21.3.5.4. Product Portfolio
21.3.5.5. Profitability by Market Segments (Product and Region)
21.3.5.6. Sales Footprint
21.3.5.7. Strategy Overview
21.3.5.7.1. Marketing Strategy
21.3.5.7.2. Product Strategy
21.3.5.7.3. Channel Strategy
21.3.6. WyMedical Pty Ltd
21.3.6.1. Company Overview
21.3.6.2. Analyst Commentary
21.3.6.3. Financial Analysis
21.3.6.4. Product Portfolio
21.3.6.5. Profitability by Market Segments (Product and Region)
21.3.6.6. Sales Footprint
21.3.6.7. Strategy Overview
21.3.6.7.1. Marketing Strategy
21.3.6.7.2. Product Strategy
21.3.6.7.3. Channel Strategy
21.3.7. AirPhysio
21.3.7.1. Company Overview
21.3.7.2. Analyst Commentary
21.3.7.3. Financial Analysis
21.3.7.4. Product Portfolio
21.3.7.5. Profitability by Market Segments (Product and Region)
21.3.7.6. Sales Footprint
21.3.7.7. Strategy Overview
21.3.7.7.1. Marketing Strategy
21.3.7.7.2. Product Strategy
21.3.7.7.3. Channel Strategy
21.3.8. Medica Holdings, LLC.
21.3.8.1. Company Overview
21.3.8.2. Analyst Commentary
21.3.8.3. Financial Analysis
21.3.8.4. Product Portfolio
21.3.8.5. Profitability by Market Segments (Product and Region)
21.3.8.6. Sales Footprint
21.3.8.7. Strategy Overview
21.3.8.7.1. Marketing Strategy
21.3.8.7.2. Product Strategy
21.3.8.7.3. Channel Strategy
21.3.9. D-R BURTON HEALTHCARE
21.3.9.1. Company Overview
21.3.9.2. Analyst Commentary
21.3.9.3. Financial Analysis
21.3.9.4. Product Portfolio
21.3.9.5. Profitability by Market Segments (Product and Region)
21.3.9.6. Sales Footprint
21.3.9.7. Strategy Overview
21.3.9.7.1. Marketing Strategy
21.3.9.7.2. Product Strategy
21.3.9.7.3. Channel Strategy
22. Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 02: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 03: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 04: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
Table 05: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 06: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 07: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 08: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 09: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 10: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 11: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 12: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 13: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 14: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 15: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 16: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 17: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 18: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 19: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 20: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 21: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 22: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 23: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 24: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 25: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 26: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 27: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 28: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 29: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country
Table 30: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 31: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 32: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 33: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 34: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 35: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 36: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 37: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 38: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Table 39: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Table 40: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Table 41: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Market Value ($ Million), By Country (2022)
Figure 02: (Per Unit) - Pricing Analysis (US$), By Region, 2022
Figure 03: (Per Unit) - Pricing Analysis (US$), By Region, 2029
Figure 04: Global Historical Market Size and Y-o-Y, 2014 to 2021
Figure 05: Global Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 06: Global Market Absolute $ Opportunity, 2014 to 2029
Figure 07: Global Market Analysis by Product Type –2022 & 2029
Figure 08: Global Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 09: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type
Figure 10: Global Market Analysis by Indication –2022 & 2029
Figure 11: Global Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 12: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
Figure 13: Global Market Analysis by Distribution Channel –2022 & 2029
Figure 14: Global Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 15: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Distribution Channel
Figure 16: Global Market Analysis by Region –2022 & 2029
Figure 17: Global Market Y-o-Y Growth Projections by Region, 2022 to 2029
Figure 18: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
Figure 19: North America Market Size (US$ Million) Analysis, 2014 to 2021
Figure 20: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 21: North America Market Analysis by Country –2022 & 2029
Figure 22: North America Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2029
Figure 24: North America Market Analysis by Product Type–2022 & 2029
Figure 25: North America Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 26: North America Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 27: North America Market Analysis by Indication – 2022 & 2029
Figure 28: North America Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 29: North America Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 30: North America Market Analysis by Distribution Channel – 2022 & 2029
Figure 31: North America Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 32: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 33: Latin America Market Size (US$ Million) Analysis, 2014 to 2021
Figure 34: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 35: Latin America Market Analysis by Country –2022 & 2029
Figure 36: Latin America Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 37: Latin America Market Attractiveness Analysis by Country, 2022 to 2029
Figure 38: Latin America Market Analysis by Product Type–2022 & 2029
Figure 39: Latin America Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 40: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 41: Latin America Market Analysis by Indication – 2022 & 2029
Figure 42: Latin America Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 43: Latin America Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 44: Latin America Market Analysis by Distribution Channel – 2022 & 2029
Figure 45: Latin America Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 46: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 47: Europe Market Size (US$ Million) Analysis, 2014 to 2021
Figure 48: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 50: Europe Market Analysis by Country –2022 & 2029
Figure 51: Europe Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 52: Europe Market Attractiveness Analysis by Country, 2022 to 2029
Figure 53: Europe Market Analysis by Product Type–2022 & 2029
Figure 54: Europe Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 55: Europe Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 56: Europe Market Analysis by Indication – 2022 & 2029
Figure 57: Europe Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 58: Europe Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 59: Europe Market Analysis by Distribution Channel – 2022 & 2029
Figure 60: Europe Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 61: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 62: South Asia Market Size (US$ Million) Analysis, 2014 to 2021
Figure 63: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 64: South Asia Market Analysis by Country –2022 & 2029
Figure 65: South Asia Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 66: South Asia Market Attractiveness Analysis by Country, 2022 to 2029
Figure 67: South Asia Market Analysis by Product Type–2022 & 2029
Figure 68: South Asia Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 69: South Asia Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 70: South Asia Market Analysis by Indication – 2022 & 2029
Figure 71: South Asia Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 72: South Asia Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 73: South Asia Market Analysis by Distribution Channel – 2022 & 2029
Figure 74: South Asia Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 75: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 76: East Asia Market Size (US$ Million) Analysis, 2014 to 2021
Figure 77: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 78: East Asia Market Analysis by Country –2022 & 2029
Figure 79: East Asia Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 80: East Asia Market Attractiveness Analysis by Country, 2022 to 2029
Figure 81: East Asia Market Analysis by Product Type–2022 & 2029
Figure 82: East Asia Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 83: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 84: East Asia Market Analysis by Indication – 2022 & 2029
Figure 85: East Asia Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 86: East Asia Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 87: East Asia Market Analysis by Distribution Channel – 2022 & 2029
Figure 88: East Asia Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 89: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 90: Oceania Market Size (US$ Million) Analysis, 2014 to 2021
Figure 91: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 92: Oceania Market Analysis by Country –2022 & 2029
Figure 93: Oceania Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 94: Oceania Market Attractiveness Analysis by Country, 2022 to 2029
Figure 95: Oceania Market Analysis by Product Type–2022 & 2029
Figure 96: Oceania Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 97: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 98: Oceania Market Analysis by Indication – 2022 & 2029
Figure 99: Oceania Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 100: Oceania Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 101: Oceania Market Analysis by Distribution Channel – 2022 & 2029
Figure 102: Oceania Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 103: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 104: MEA Market Size (US$ Million) Analysis, 2014 to 2021
Figure 105: MEA Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 106: MEA Market Analysis by Country –2022 & 2029
Figure 107: MEA Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 108: MEA Market Attractiveness Analysis by Country, 2022 to 2029
Figure 109: MEA Market Analysis by Product Type–2022 & 2029
Figure 110: MEA Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 111: MEA Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 112: MEA Market Analysis by Indication – 2022 & 2029
Figure 113: MEA Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 114: MEA Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 115: MEA Market Analysis by Distribution Channel – 2022 & 2029
Figure 116: MEA Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 117: MEA Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 118: Emerging Countries Market Value Share (2022 E)
Figure 119: Emerging Countries Market Value (US$ Million), By Key Countries, 2014-2029
Figure 120: China Market Size (US$ Million) Analysis, 2014 to 2021
Figure 121: China Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 122: China Market Analysis by Product Type–2022 & 2029
Figure 123: China Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 124: China Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 125: China Market Analysis by Indication – 2022 & 2029
Figure 126: China Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 127: China Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 128: China Market Analysis by Distribution Channel – 2022 & 2029
Figure 129: China Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 130: China Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 131: India Market Size (US$ Million) Analysis, 2014 to 2021
Figure 132: India Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 133: India Market Analysis by Product Type–2022 & 2029
Figure 134: India Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 135: India Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 136: India Market Analysis by Indication – 2022 & 2029
Figure 137: India Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 138: India Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 139: India Market Analysis by Distribution Channel – 2022 & 2029
Figure 140: India Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 141: India Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 142: Brazil Market Size (US$ Million) Analysis, 2014 to 2021
Figure 143: Brazil Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 144: Brazil Market Analysis by Product Type–2022 & 2029
Figure 145: Brazil Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 146: Brazil Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 147: Brazil Market Analysis by Indication – 2022 & 2029
Figure 148: Brazil Market Y-o-Y Growth Projections by Indication, 2022 to 2029
Figure 149: Brazil Market Attractiveness Analysis by Indication, 2022 to 2029
Figure 150: Brazil Market Analysis by Distribution Channel – 2022 & 2029
Figure 151: Brazil Market Y-o-Y Growth Projections by Distribution Channel, 2022 to 2029
Figure 152: Brazil Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
